Stay updated with breaking news from Bright Path Labs. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Covira, a Chicago-area based microbiome-focused biotech company focused on developing novel therapeutic agents that modulate the gut microbiome...
/PRNewswire/ -- The use of artificial intelligence in API manufacturing is gaining popularity among the pharmaceutical API manufacturing market trends. Players...
The Business Research Company's pharmaceutical API manufacturing market research report expands on key drivers, trends, and growth opportunities in the market. LONDON, Sept. 8, 2022 /PRNewswire/
Headquartered at Hong Kong, Rupus Global Limited (To accelerate its growth engine by revenueamp;global expansion, Rupus Global Limited is exploring new partnership
California [US], May 10 (ANI/NewsVoir): Headquartered at Hong Kong, Rupus Global Limited (rupusglobal.com), one of the fastest growing pharmaceutical company with leadership position in active pharmaceutical ingredients (APIs), finished dosage forms (FDFs) and provides contract research and manufacturing services (CRAMS) in key segments such as Anti-Inflammatory, Anti-Protozoal, Anti-Diabetic, Vitamins, Anti-Malarial, Anti Cancer has set out an ambitious goal to boost its revenue for 225 Million USD by 2023-24.